As crosstalk between tumor cells and the immune system is generally considered a pivotal factor in CRC development,23 we hypothesized that the murine immune system may contribute to the tumor‐promoting function of NFKB2 in syngeneic mouse models. This evidence concerns the gene NFKB2 and colorectal carcinoma.